ChemoMetec A/S (CHEMM.CO)

DKK 486.8

(2.83%)

EBITDA Summary of ChemoMetec A/S

  • ChemoMetec A/S's latest annual EBITDA in 2024 was 193.97 Million DKK , down -20.95% from previous year.
  • ChemoMetec A/S's latest quarterly EBITDA in 2024 FY was N/A , down -23.02% from previous quarter.
  • ChemoMetec A/S reported an annual EBITDA of 245.38 Million DKK in 2023, up 12.11% from previous year.
  • ChemoMetec A/S reported an annual EBITDA of 218.53 Million DKK in 2022, up 67.63% from previous year.
  • ChemoMetec A/S reported a quarterly EBITDA of N/A for 2024 FY, down -23.02% from previous quarter.
  • ChemoMetec A/S reported a quarterly EBITDA of 44.89 Million DKK for 2024 Q1, down -57.76% from previous quarter.

Annual EBITDA Chart of ChemoMetec A/S (2024 - 2004)

Historical Annual EBITDA of ChemoMetec A/S (2024 - 2004)

Year EBITDA EBITDA Growth
2024 193.97 Million DKK -20.95%
2023 245.38 Million DKK 12.11%
2022 218.53 Million DKK 67.63%
2021 129 Million DKK 45.35%
2020 91.92 Million DKK 41.41%
2019 61.15 Million DKK 117.62%
2018 29.97 Million DKK 97.67%
2017 15.39 Million DKK -30.14%
2016 21.51 Million DKK 71.24%
2015 12.67 Million DKK 80.61%
2014 7.01 Million DKK -5.1%
2013 7.39 Million DKK -17.38%
2012 9.5 Million DKK 11.19%
2011 8.05 Million DKK 56.88%
2010 4.83 Million DKK 15.98%
2009 5.05 Million DKK -72.54%
2008 16.11 Million DKK 646.27%
2007 2.15 Million DKK 14.9%
2006 1.87 Million DKK 146.26%
2005 1.06 Million DKK 110.63%
2004 -7.17 Million DKK 0.0%

Peer EBITDA Comparison of ChemoMetec A/S

Name EBITDA EBITDA Difference
Ambu A/S 691 Million DKK 71.928%
Demant A/S 5.21 Billion DKK 96.283%
GN Store Nord A/S 2.31 Billion DKK 91.614%
Scandinavian Medical Solutions A/S 21.22 Million DKK -813.892%
ViroGates A/S -12.48 Million DKK 1654.178%